Skip to main content
Top
Published in: Annals of Hematology 4/2015

01-04-2015 | Letter to the Editor

Unilateral hearing loss due to lymphocytosis and a contralateral putamen lesion

Authors: Hilda Wong, Yu-Yan Hwang, Rock Y. Y. Leung, Gavin S. W. Chan, Pek-Lan Khong, Yok-Lam Kwong

Published in: Annals of Hematology | Issue 4/2015

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Kwong YL, Pang AW, Leung AY, Chim CS, Tse E (2014) Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance. Leukemia 28(4):865–70CrossRefPubMed Kwong YL, Pang AW, Leung AY, Chim CS, Tse E (2014) Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance. Leukemia 28(4):865–70CrossRefPubMed
3.
go back to reference Tanaka Y, Kamo T, Yoshida M, Yamadori A (1991) ‘So-called’ cortical deafness. Clinical, neurophysiological and radiological observations. Brain 114 (Pt 6):2385–2401 Tanaka Y, Kamo T, Yoshida M, Yamadori A (1991) ‘So-called’ cortical deafness. Clinical, neurophysiological and radiological observations. Brain 114 (Pt 6):2385–2401
Metadata
Title
Unilateral hearing loss due to lymphocytosis and a contralateral putamen lesion
Authors
Hilda Wong
Yu-Yan Hwang
Rock Y. Y. Leung
Gavin S. W. Chan
Pek-Lan Khong
Yok-Lam Kwong
Publication date
01-04-2015
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 4/2015
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-014-2225-7

Other articles of this Issue 4/2015

Annals of Hematology 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine